Lung Ultrasonography After Laparoscopic Gynecologic Surgery (LUS-LPS)

October 25, 2021 updated by: SONNINO CHIARA

Lung Ultrasonography for the Assessment of Perioperative Atelectasis After Laparoscopic Gynecologic Oncologic Surgery

This study evaluates the influence of surgical and anesthesia-related variable on atelectasis formation during laparoscopic gynecologic oncologic surgery by lung ultrasound.

Study Overview

Status

Completed

Detailed Description

Approximately 50% of patients undergoing general anesthesia are hypoxemic. Anaesthesia, paralysis, high concentrations of oxygen, inadequate level of PEEP, capnoperitoneum, Trendelenburg position all result in persistent atelectasis. Lung ultrasound is a safe and accurate bedside tool useful to study lung aeration. The aim of the investigator's study was to assess the impact of general anesthesia and laparoscopic gynecologic oncologic surgery on post-operative atelectasis and related oxygenation changes using lung ultrasound.

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rome, Italy, 00168
        • IRCCS Fondazione Policlinico Universitario Agostino Gemelli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

All patients >18yo undergoing laparoscopy for ginecologic oncologic surgery willing to participate to the study

Description

Inclusion Criteria:

  • Patients older than 18 yo undergoing laparoscopic surgery for gynecologic surgery who provide written informed consent.

Exclusion Criteria:

  • age < 18 yo;
  • pregnancy;
  • refused to partecipate;
  • known pulmonary metastasis;
  • preexisting pulmonary conditions (COPD, pleural effusion, pulmonary consolidations, lung edema, pulmonary embolism);
  • anesthesia with mechanical ventilation in the 2 weeks.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess if LUS score measured after surgery is higher that LUS score measured before induction of anesthesia
Time Frame: The outcome will be measured 10 minutes after extubation
Each lung will be divided in 6 areas and a score from 0 to 3 will be assigned to each field depending on the loss of aereation detected by ultrasound. LUS score will range between 0 and 36. Lung ultrasound will be performed before induction of anesthesia and 10 minutes after extubation.
The outcome will be measured 10 minutes after extubation
Correlation between the increase of LUS score after surgery and surgical or anesthesia-related variables.
Time Frame: The outcome will be measured 10 minutes after extubation

Logistic regression will be applied to consider the correlation between Delta LUS and the following variables:

  • lenght of surgery
  • duration of pneumoperitoneum
  • angle of Trendelenburg potision
  • duration of mechanical ventilation
  • intraoperative fluids
  • duration of apnea from induction to intubation
The outcome will be measured 10 minutes after extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Luciano Frassanito, MD, IRCCS Fondazione Universitaria Policlinico Agostino Gemelli
  • Study Director: Gaetano Draisci, MD, PhD, IRCCS Fondazione Universitaria Policlinico Agostino Gemelli

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 3, 2018

Primary Completion (ACTUAL)

October 3, 2018

Study Completion (ACTUAL)

June 28, 2019

Study Registration Dates

First Submitted

July 27, 2019

First Submitted That Met QC Criteria

October 3, 2019

First Posted (ACTUAL)

October 4, 2019

Study Record Updates

Last Update Posted (ACTUAL)

November 1, 2021

Last Update Submitted That Met QC Criteria

October 25, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Atelectasis

Subscribe